These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11418633)

  • 1. Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells.
    Shirota H; Sano K; Hirasawa N; Terui T; Ohuchi K; Hattori T; Shirato K; Tamura G
    J Immunol; 2001 Jul; 167(1):66-74. PubMed ID: 11418633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator.
    Shirota H; Sano K; Kikuchi T; Tamura G; Shirato K
    J Immunol; 2000 Jun; 164(11):5575-82. PubMed ID: 10820231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12.
    Shirota H; Sano K; Hirasawa N; Terui T; Ohuchi K; Hattori T; Tamura G
    J Immunol; 2002 Jul; 169(2):787-94. PubMed ID: 12097381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner.
    Sano K; Shirota H; Terui T; Hattori T; Tamura G
    J Immunol; 2003 Mar; 170(5):2367-73. PubMed ID: 12594259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG-DNA aided cross-priming by cross-presenting B cells.
    Heit A; Huster KM; Schmitz F; Schiemann M; Busch DH; Wagner H
    J Immunol; 2004 Feb; 172(3):1501-7. PubMed ID: 14734727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
    Warren TL; Bhatia SK; Acosta AM; Dahle CE; Ratliff TL; Krieg AM; Weiner GJ
    J Immunol; 2000 Dec; 165(11):6244-51. PubMed ID: 11086059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
    Jakob T; Walker PS; Krieg AM; Udey MC; Vogel JC
    J Immunol; 1998 Sep; 161(6):3042-9. PubMed ID: 9743369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.
    Maurer T; Heit A; Hochrein H; Ampenberger F; O'Keeffe M; Bauer S; Lipford GB; Vabulas RM; Wagner H
    Eur J Immunol; 2002 Aug; 32(8):2356-64. PubMed ID: 12209649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
    Askew D; Chu RS; Krieg AM; Harding CV
    J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.
    Kamath AT; Mastelic B; Christensen D; Rochat AF; Agger EM; Pinschewer DD; Andersen P; Lambert PH; Siegrist CA
    J Immunol; 2012 May; 188(10):4828-37. PubMed ID: 22504654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells.
    Heit A; Maurer T; Hochrein H; Bauer S; Huster KM; Busch DH; Wagner H
    J Immunol; 2003 Mar; 170(6):2802-5. PubMed ID: 12626528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
    J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratracheal priming with ovalbumin- and ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyperresponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation.
    Sung S; Rose CE; Fu SM
    J Immunol; 2001 Jan; 166(2):1261-71. PubMed ID: 11145709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.
    Hartmann G; Weiner GJ; Krieg AM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9305-10. PubMed ID: 10430938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice.
    Shibuya K; Robinson D; Zonin F; Hartley SB; Macatonia SE; Somoza C; Hunter CA; Murphy KM; O'Garra A
    J Immunol; 1998 Feb; 160(4):1708-16. PubMed ID: 9469428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease.
    Visser L; Jan de Heer H; Boven LA; van Riel D; van Meurs M; Melief MJ; Zähringer U; van Strijp J; Lambrecht BN; Nieuwenhuis EE; Laman JD
    J Immunol; 2005 Jan; 174(2):808-16. PubMed ID: 15634902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization.
    Kuipers H; Heirman C; Hijdra D; Muskens F; Willart M; van Meirvenne S; Thielemans K; Hoogsteden HC; Lambrecht BN
    J Leukoc Biol; 2004 Nov; 76(5):1028-38. PubMed ID: 15316032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo generated Th1 cells can migrate to B cell follicles to support B cell responses.
    Smith KM; Brewer JM; Rush CM; Riley J; Garside P
    J Immunol; 2004 Aug; 173(3):1640-6. PubMed ID: 15265892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.